EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSCCRG00000040030
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSCCRG00000035856
Gene Symbol: ADRB2A
1 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSCCRG00000055158
Gene Symbol: ADRB2A
1 Cross references
193 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSCCRG00000001815
Gene Symbol: ADRB3A
1 Cross references
193 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSCCRG00000072214
Gene Symbol: ADRB3A
1 Cross references
194 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSCCRG00000008526
Gene Symbol: ADRB3B
1 Cross references
143 Possible Orthologues:

Adrenoceptor Beta 3b

Ensembl ID : ENSCCRG00000029215
Gene Symbol: ADRB3B
1 Cross references
143 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSCCRG00000059631
Gene Symbol: AKR1B1.1
1 Cross references
345 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSCCRG00000016111
Gene Symbol: AKR1B1.1
1 Cross references
346 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSCCRG00000063182
Gene Symbol: AKR1B1.2
1 Cross references
344 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 2

Ensembl ID : ENSCCRG00000001707
Gene Symbol: AKR1B1.2
1 Cross references
346 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCCRG00000041310
Gene Symbol: AOC1
1 Cross references
229 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).